The US National Institute of Health's National Center for Advancing Translational Science has announced that five more pharmaceutical companies have joined its program to find new uses for early-stage drugs that did not make it through the full pipeline, reports ScienceInsider's Jocelyn Kaiser.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.